JMP Securities Downgrades Carbylan Therapeutics (CBYL) to Market Perform
Tweet
Share
E-mailGet Alerts CBYL Hot Sheet
Price: $0.68 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
JMP Securities downgraded Carbylan Therapeutics (NASDAQ: CBYL) from Market Outperform to Market Perform.
For an analyst ratings summary and ratings history on Carbylan Therapeutics click here. For more ratings news on Carbylan Therapeutics click here.
Shares of Carbylan Therapeutics closed at $0.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades PWR Holdings Ltd. (PWH:AU) to Equalweight
- HSBC Downgrades Kakao Corp. (035720:KS) to Hold
- JPMorgan Upgrades Diploma Plc. (DPLM:LN) to Overweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
